# Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rodabe N. Amaria,Sangeetha M. Reddy,Hussein A. Tawbi,Michael A. Davies,Merrick I. Ross,Isabella C. Glitza,Janice N. Cormier,Carol M. Lewis,Wen-Jen Hwu,Ehab Hanna,Adi Diab,Michael K. Wong,Richard E. Royal,Neil D. Gross,Randal S. Weber,Stephen Y. Lai,Richard A. Ehlers,Jorge Blando,Denái R. Milton,Scott E. Woodman,Robin Kageyama,Daniel K. Wells,Patrick Hwu,Sapna P. Patel,Anthony Lucci,Amy C. Hessel,Jeffrey E. Lee,Jeffrey E. Gershenwald,Lauren Simpson,Elizabeth M. Burton,Liberty Posada,Lauren E. Haydu,Linghua Wang,Shaojun Zhang,Alexander J. Lazar,Courtney W. Hudgens,Vancheswaran Gopalakrishnan,Alexandre Reuben,Miles C. Andrews,Christine N. Spencer,Víctor G. Prieto,Padmanee Sharma,James P. Allison,Michael T. Tetzlaff,Jennifer A. Wargo |
| Citations | 830 |
| DOI | 10.1038/s41591-018-0197-1 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/6481682 |
| OpenAlex ID | https://openalex.org/W2894584497 |
| PMID | 30297909 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Anthony Lucci](https://scholariq.org/researchers/anthony-lucci/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.